Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
AIDS (London, England)|December 5, 2015
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairmentAndrea Calcagno, Jessica Cusato, Letizia Marinaro, et al.
Journal of Reproductive Immunology|February 14, 2021
Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to deliveryStefano Cosma, Andrea Roberto Carosso, Silvia Corcione, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2023
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS KitJacopo Mula, Francesco Chiara, Alessandra Manca, et al.
Pharmacogenetics and Genomics|March 26, 2013
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotaneAntonio D'Avolio, Silvia De Francia, Vittoria Basile, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2012
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cellsAntonio D'Avolio, Marco Simiele, Andrea Calcagno, et al.
AIDS (London, England)|May 5, 2024
Association between tight junction proteins and cognitive performance in untreated persons with HIVFrancesca Bai, Valeria Bono, Lidia Borghi, et al.
Pharmaceutics|May 4, 2026
UHPLC-MS/MS Method for the Simultaneous Quantification of 12 Antiretroviral Drugs in Human Plasma Using Dried Sample Spot Devices: Development, Validation, and Stability EvaluationSara Soloperto, Elisa Martina, Alice Palermiti, et al.
Metabolites|December 23, 2022
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic StudyJessica Cusato, Alberto Borghetti, Elisabetta Teti, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 17, 2018
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patientsJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Pageof 16